FindTrial
Sign In

Phosphate Buffered Saline

OTHER9 trials

Sponsors

Genzyme, a Sanofi Company, Bioventus LLC, Alachua Government Services, Inc., BiondVax Pharmaceuticals ltd., U.S. Army Medical Research and Development Command

Conditions

AlopeciaDengue FeverDermatitisHealthyInfluenzaMale Pattern Hair LossMusculoskeletal DiseasesOsteoarthritis of the Shoulder

Phase 1

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)
CompletedNCT00877448
BiondVax Pharmaceuticals ltd.Healthy
Start: 2009-06-30End: 2009-11-30Updated: 2023-03-07
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
CompletedNCT01666652
U.S. Army Medical Research and Development CommandDengue Fever
Start: 2012-09-30End: 2017-11-30Updated: 2019-01-25
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
CompletedNCT01702857
U.S. Army Medical Research and Development CommandDengue Fever
Start: 2012-11-30End: 2017-03-23Updated: 2017-05-23
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
NCT03662854
HistogenAlopecia
Start: 2018-07-02End: 2021-01-21Updated: 2019-02-21
Safety and Efficacy of HST 001 in Male Pattern Hair Loss
CompletedNCT04435847
HistogenMale Pattern Hair Loss
Start: 2020-05-26End: 2021-01-20Updated: 2021-03-19

Phase 3

A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee
CompletedNCT00131352
Genzyme, a Sanofi CompanyMusculoskeletal Diseases, Osteoarthritis, Knee
Start: 2005-05-31End: 2006-09-30Updated: 2015-04-03
Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)
CompletedNCT00566345
Alachua Government Services, Inc.Influenza
Start: 2007-11-30End: 2008-06-30Updated: 2023-10-17

Unknown Phase

SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder
CompletedNCT00479687
Bioventus LLCOsteoarthritis of the Shoulder
Start: 2007-05-31End: 2009-10-31Updated: 2021-04-27
Infant Fecal Insult Study
CompletedNCT02979210
Kimberly-Clark CorporationDermatitis
Start: 2016-11-30End: 2017-02-01Updated: 2017-08-18

Related Papers

Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults.
2022-10-317 citations
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study
American Journal of Tropical Medicine and Hygiene2020-03-0314 citations
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions
Human Vaccines & Immunotherapeutics2019-03-046 citations
Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico
American Journal of Tropical Medicine and Hygiene2018-03-0643 citations
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States
American Journal of Tropical Medicine and Hygiene2017-03-1464 citations
A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.
2012-01-1922 citations
Clinical development of a Vero cell culture-derived seasonal influenza vaccine.
2011-12-1323 citations
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial.
2011-02-1577 citations